When considering Oculinum (botulinum toxin type A) injection for the treatment of strabismus, can the surgeon anticipate different results in patients who have had previous strabismus surgery?
Arch Ophthalmol
.
1991 Nov;109(11):1510.
doi: 10.1001/archopht.1991.01080110044031.
Author
A B Scott
1
Affiliation
1
Allergan Pharmaceuticals, Irvine, Calif.
PMID:
1755729
DOI:
10.1001/archopht.1991.01080110044031
No abstract available
MeSH terms
Adult
Botulinum Toxins / therapeutic use*
Humans
Injections
Reoperation
Strabismus / therapy*
Treatment Outcome
Substances
Botulinum Toxins